However, a meta-analysis demonstrated that the mortality risk was considerably higher for people who had Her3 overexpression rather than for those with lower expression in solid tumors.[25] The results of the present study corroborate with those of previous studies, suggesting that Her3 overexpression is associated with CRC. Here, ERBB3 is linked to colorectal carcinoma.